Lundbeck says Alzheimer's late-stage study fails

Sept 22 (Reuters) - Danish drugmaker H Lundbeck A/S said its late-stage study testing an experimental drug to treat mild to moderate Alzheimer's disease failed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.